Literature DB >> 15052680

Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers.

Yung-Chih Lai1, Jyh-Chin Yang, Shih-Hung Huang.   

Abstract

AIM: To evaluate the association of pre-treatment (13)C-urea breath test (UBT) results with H pylori density and efficacy of eradication therapy in patients with active duodenal ulcers.
METHODS: One hundred and seventeen consecutive outpatients with active duodenal ulcer and H pylori infection were recruited. H pylori density was histologically graded according to the Sydney system. Each patient received lansoprazole (30 mg b.i.d.), clarithromycin (500 mg b.i.d.) and amoxicillin (1 g b.i.d.) for 1 week. According to pre-treatment UBT values, patients were allocated into low (<16 per thousand), intermediate (16-35 per thousand), and high (>35 per thousand) UBT groups.
RESULTS: A significant correlation was found between pre-treatment UBT results and H pylori density (P<0.001). H pylori eradication rates were 94.9%, 94.4% and 81.6% in the low, intermediate and high UBT groups, respectively (per protocol analysis, P=0.11). When patients were assigned into two groups (UBT results < or =35 per thousand and >35 per thousand), the eradication rates were 94.7% and 81.6%, respectively (P=0.04).
CONCLUSION: The intragastric bacterial load of H pylori can be evaluated by UBT, and high pre-treatment UBT results can predict an adverse outcome of eradication therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052680      PMCID: PMC4717118          DOI: 10.3748/wjg.v10.i7.991

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.

Authors:  F Perri; R Clemente; V Festa; M Quitadamo; P Conoscitore; G Niro; Y Ghoos; P Rutgeerts; A Andriulli
Journal:  Ital J Gastroenterol Hepatol       Date:  1998-04

2.  Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?

Authors:  G Maconi; F Parente; A Russo; L Vago; V Imbesi; G Bianchi Porro
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

3.  A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.

Authors:  M Asaka; T Sugiyama; M Kato; K Satoh; H Kuwayama; Y Fukuda; T Fujioka; T Takemoto; K Kimura; T Shimoyama; K Shimizu; S Kobayashi
Journal:  Helicobacter       Date:  2001-09       Impact factor: 5.753

4.  pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.

Authors:  R H Hunt
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

5.  Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

Authors:  F Perri; M R Villani; V Festa; M Quitadamo; A Andriulli
Journal:  Aliment Pharmacol Ther       Date:  2001-07       Impact factor: 8.171

Review 6.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

7.  Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.

Authors:  Yung-Chih Lai; Teh-Hong Wang; Shih-Hung Huang; Sien-Sing Yang; Chi-Hwa Wu; Tzen-Kwan Chen; Chia-Long Lee
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 8.  Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia.

Authors:  J G Penston
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

9.  Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution.

Authors:  R M Genta; D Y Graham
Journal:  Gastrointest Endosc       Date:  1994 May-Jun       Impact factor: 9.427

10.  Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.

Authors:  S W Hosking; T K Ling; S C Chung; M Y Yung; A F Cheng; J J Sung; A K Li
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

View more
  8 in total

1.  Role of gastritis pattern on Helicobacter pylori eradication.

Authors:  Angelo Zullo; Carola Severi; Lucy Vannella; Cesare Hassan; Andrea Sbrozzi-Vanni; Bruno Annibale
Journal:  Intern Emerg Med       Date:  2011-11-22       Impact factor: 3.397

2.  Helicobacter pylori therapy: Present and future.

Authors:  Vincenzo De Francesco; Enzo Ierardi; Cesare Hassan; Angelo Zullo
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

3.  13C-urea breath test values and Helicobacter pylori eradication.

Authors:  Angelo Zullo; Federico Perna; Chiara Ricci; Cesare Hassan; Andrea Tampieri; Vincenzo De Francesco; Sergio Morini; Dino Vaira
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

Review 4.  The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.

Authors:  Angelo Zullo; Vincenzo De Francesco; Cesare Hassan; Sergio Morini; Dino Vaira
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

5.  Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.

Authors:  György M Buzás; Ilona Széles
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

Review 6.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

7.  Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

Authors:  Javier P Gisbert; Xavier Calvet
Journal:  Clin Exp Gastroenterol       Date:  2012-03-13

Review 8.  Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation.

Authors:  Muhammad Miftahussurur; Yoshio Yamaoka
Journal:  Biomed Res Int       Date:  2016-01-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.